Celgene Corporation
Registered Principal Details
Business Or Interest:
Biopharmaceutical company.
Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.
CEO Name:
Col Barer
Vice President
Biopharmaceutical company.
Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.
CEO Name:
Col Barer
Vice President
Contact
AMF
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Greg Chesmore | Exclusive Duties N/A | Authorized On 1/27/2009 | Withdrawn On N/A |
| Kelly McDowell | Exclusive Duties N/A | Authorized On 10/1/2010 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 56
Relating to: advertising for prescription drugs.
Bill Text and History
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: advertising for prescription drugs.
Bill Text and History
Against
Notification Date7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 272
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Celgene supports the language in AB 272 which prohibits donation and redistribution prescription drugs subject to FDA-mandated restricted distribution programs.
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
For
Notification Date7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Celgene supports the language in AB 272 which prohibits donation and redistribution prescription drugs subject to FDA-mandated restricted distribution programs.
Assembly Bill 947
Relating to: requiring certain identification in order to vote at a polling place or obtain an absentee ballot, verification of the addresses of electors, absentee voting procedure in certain residential care apartment complexes and adult family homes, ide...
Bill Text and History
4/23/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Requiring parity in health coverage (patient out of pocket expenses) for oral and IV/infused oncology therapies.
Relating to: requiring certain identification in order to vote at a polling place or obtain an absentee ballot, verification of the addresses of electors, absentee voting procedure in certain residential care apartment complexes and adult family homes, ide...
Bill Text and History
For
Notification Date4/23/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Requiring parity in health coverage (patient out of pocket expenses) for oral and IV/infused oncology therapies.
Assembly Bill 974
Relating to: insurance coverage of oral and injected chemotherapy.
Bill Text and History
6/9/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Parity in health insurance coverage of oral chemotherapy products
Relating to: insurance coverage of oral and injected chemotherapy.
Bill Text and History
For
Notification Date6/9/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Parity in health insurance coverage of oral chemotherapy products
Senate Bill 198
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
For
Notification Date1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Development, drafting or introduction of a proposal relating to
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
Action Intended To Affect
Legislative Matter
Notification Date
2/4/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
2/4/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Bills to revamp Wisconsin's cancer and chronic disease drug repository program.
Bills to revamp Wisconsin's cancer and chronic disease drug repository program.
Action Intended To Affect
Legislative Matter
Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Draft resolution regarding placenta blood/cord blood banking and research.
Draft resolution regarding placenta blood/cord blood banking and research.
Action Intended To Affect
Legislative Matter
Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/19/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Development, drafting or introduction of a proposal relating to
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Potential Assembly Resolution regarding public awareness of cord blood/placenta blood banking and research.
Action Intended To Affect
Legislative Matter
Notification Date
11/10/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
11/10/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Development, drafting or introduction of a proposal relating to
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
Action Intended To Affect
Rule (by a state agency)
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Rule (by a state agency)
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
Development, drafting or introduction of a proposal relating to
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
Action Intended To Affect
Legislative Matter
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
7/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2009 January - June $8,706.21 |
2009 July - December $1,421.87 |
2010 January - June $5,761.06 |
2010 July - December $7,516.27 |
Total $23,405.41 |
| Total Hours Communicating | 2009 January - June 23.75 |
2009 July - December 6.00 |
2010 January - June 15.00 |
2010 July - December 14.00 |
Total 58.75 |
| Total Hours Other | 2009 January - June 33.50 |
2009 July - December 5.00 |
2010 January - June 25.00 |
2010 July - December 54.00 |
Total 117.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: advertising for prescription drugs.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 5% |
2009 July - December |
2010 January - June |
2010 July - December |
Total 2% |
Relating to: donating drugs and dispensing donated drugs.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 50% |
2009 July - December 50% |
2010 January - June |
2010 July - December |
Total 20% |
Relating to: donating drugs and dispensing donated drugs.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June |
2009 July - December 50% |
2010 January - June 20% |
2010 July - December |
Total 8% |
Relating to: insurance coverage of oral and injected chemotherapy.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June |
2009 July - December |
2010 January - June 65% |
2010 July - December 50% |
Total 34% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
The lack of necessity for new laws restricting the access of pharmaceutical sales representatives and promoting the role these professionals have working with physicians to ensure patient access to needed drugs.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 15% |
2009 July - December |
2010 January - June 10% |
2010 July - December |
Total 7% |
Seeking agency action within the Department of Health Services to ensure that FDA-mandated restricted distribution drugs are not accepted and redispensed in violation of FDA risk management programs.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 30% |
2009 July - December |
2010 January - June |
2010 July - December |
Total 10% |
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June |
2009 July - December |
2010 January - June 5% |
2010 July - December |
Total 1% |
Oral Oncology Fairness: legislation requiring coverage of oral cancer therapies to be no less favorable than injectable/IV therapies.
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December 50% |
Total 19% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.